Skip to main content

Market Overview

BioLife Solutions: Q4 Earnings Insights


Shares of BioLife Solutions (NASDAQ:BLFS) rose 9.7% in after-market trading after the company reported Q4 results.

Quarterly Results

Earnings per share were down 0.00% year over year to ($0.01), which beat the estimate of ($0.02).

Revenue of $14,726,000 rose by 77.53% year over year, which beat the estimate of $13,500,000.


BioLife Solutions hasn't issued any earnings guidance for the time being.

Revenue guidance hasn't been issued by the company for now.

Details Of The Call

Date: Mar 22, 2021

Time: 04:30 PM

ET Webcast URL:


Company's 52-week high was at $47.22

Company's 52-week low was at $8.29

Price action over last quarter: Up 25.63%

Company Overview

BioLife Solutions Inc is active in the healthcare segment. The company is engaged in the developing, manufacturing and marketing a portfolio of biopreservation tools and services for cells, tissues and organs, including clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud, hosted biologistics cold chain management application for shippers. The company's product offerings include hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs.


Related Articles (BLFS)

View Comments and Join the Discussion!

Posted-In: BZI-RecapsEarnings